Skip to main content
. Author manuscript; available in PMC: 2013 Apr 27.
Published in final edited form as: Curr Neurovasc Res. 2010 May;7(2):125–135. doi: 10.2174/156720210791184880

Fig. 4.

Fig. 4

MDA and 8-OHdG immunoreactivities with or without TBI challenge. Changes in overall MDA fluorescent intensity are summarized in A, and changes in overall 8-OHdG fluorescent intensity are summarized in B. *p<0.05 vs. the 0 day (control) group.